Investors take Sinopharm’s $715m placement pill
Chinese company Sinopharm Group raised a chunky HK$5.55bn ($715m) through a private placement of shares to nine investors over the weekend, with its stock sliding by around 6% on Monday’s trading session.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts